Sydney Flannigan

Sydney Flannigan is a Senior Scientist in Bioanalysis at Eli Lilly and Company, a position held since October 2025, and previously served as a Senior Research Associate and Research Associate in Bioanalysis at Verve Therapeutics from June 2022 to October 2025. Sydney began a career in research as an Undergraduate Research Assistant at Casteel Laboratory, Cornell University, from June 2020 to May 2022, and gained practical experience as a Laboratory Intern at GENOSKIN in the summer of 2021. Educational achievements include a Bachelor's degree in Cell/Cellular and Molecular Biology from Cornell University, completed in May 2022, and a High School Diploma from Wakefield Memorial High School, awarded in 2018.